Salzer, Wanda L <br/><br/>
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.  [electronic resource] 

 -  Cancer  03 2018 
 - 1150-1159 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.31099  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--chemically induced<br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bacterial Infections--chemically induced<br/>Child<br/>Child, Preschool<br/>Clofarabine--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Pancreatitis--chemically induced<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Remission Induction--methods<br/>Severity of Illness Index<br/>Young Adult